Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.

NCT05962606 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Community-acquired Pneumonia

Interventions

DRUG: AON-D21
DRUG: Placebo

Sponsor

Aptarion Biotech AG